We have located links that may give you full text access.
JOURNAL ARTICLE
META-ANALYSIS
REVIEW
Prognostic value of microRNA-155 in human carcinomas: An updated meta-analysis.
BACKGROUND: miR-155 functions as an oncomiR or as an oncosuppressor-miR in human cancer. Although miR-155 has been researched in many cancers, its prognostic value is uncertain.
METHODS: We performed a literature search in up-to-date electronic databases including PubMed and Embase to obtain as many relevant articles as possible. Combined hazard ratios (HR) of miR-155 for outcome were analyzed.
RESULTS: A total of 24 papers researching different cancers were included in this meta-analysis. Combined HRs showed that miR-155 was significantly associated with a poorer OS with HR = 1.99 (1.34-2.96) (I-squared = 83.1%, P = 0.000). Combined HR of PFS/RFS/DFS was 1.95 (1.14-3.33) (I-squared = 75.9%, P = 0.000) and CSS/DSS was 2.50 (0.73-8.58) (I-squared = 87.7%, P = 0.000).
CONCLUSION: Increased miR-155 expression was associated with poorer survival in human carcinoma and as such may be valuable in predicting outcome.
METHODS: We performed a literature search in up-to-date electronic databases including PubMed and Embase to obtain as many relevant articles as possible. Combined hazard ratios (HR) of miR-155 for outcome were analyzed.
RESULTS: A total of 24 papers researching different cancers were included in this meta-analysis. Combined HRs showed that miR-155 was significantly associated with a poorer OS with HR = 1.99 (1.34-2.96) (I-squared = 83.1%, P = 0.000). Combined HR of PFS/RFS/DFS was 1.95 (1.14-3.33) (I-squared = 75.9%, P = 0.000) and CSS/DSS was 2.50 (0.73-8.58) (I-squared = 87.7%, P = 0.000).
CONCLUSION: Increased miR-155 expression was associated with poorer survival in human carcinoma and as such may be valuable in predicting outcome.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app